Eli Lilly, virtually alone among its large-cap pharma peers, has been having an excellent year. The stock is up by a ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The Louisiana Children's Museum (LCM) has announced a $2.5 million grant from Lilly Endowment Inc. to launch a groundbreaking ...

The meeting comes at a critical time as many U.S. businesses remain cautious, waiting for clarity on trade policies.

U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.

The (Santa Rosa) Press Democrat: Napa County’s $133 Million Jail To Open This Summer, With Shift Toward Rehabilitation, Mental Health Support Napa County’s long-anticipated new jail is slated ...

Charles Barkley is going on the offense after seeing his weight rebound. | Charles Barkley is going on the offense after ...

Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost ...

Adding nbUVB phototherapy to oral ritlecitinib improves facial and total body repigmentation in patients with nonsegmental ...

The Dow and S&P 500 look to notch a sixth day of gains as investors await more trade news and an easing of tariffs on ...

Growth stocks often don't come cheap, especially when their prospects look great, as is the case with Eli Lilly ( LLY 1.09%).

After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...